EAU prostate cancer guidelines 2019: What changed and why?
Prof Nicolas Mottet - University Hospital St Etienne, St Etienne, France
8 May 2019
Neoadjuvant treatment before radical prostatectomy: Current situation
Prof Nicolas Mottet - University Hospital St Etienne, St Etienne, France
8 May 2019
First- and second-line treatments for locally advanced renal cell carcinoma
Prof Jorge A. Garcia - Cleveland Clinic, Cleveland, USA
8 May 2019
Emerging management of metastatic castration-sensitive prostate cancer: front-li...
Prof Jorge A. Garcia - Cleveland Clinic, Cleveland, USA
8 May 2019
Highlights from IGILUC 2019
Prof Hesham El-Ghazaly - Ain Shams University, Cairo, Egypt
8 May 2019
Quality of life and local treatment of oligometastatic prostate cancer
Prof Claude Abbou - Clinique de l'Alma, Paris, France
8 May 2019
Challenges in the treatment of upper urinary tract tumours
Prof Amr Emara - Basingstoke and North Hampshire Hospital, Basingstoke, UK
8 May 2019
PARP inhibitors and their side effects in solid tumour therapy
Paula Anastasia - David Geffen School of Medicine at UCLA Los Angeles, USA
8 May 2019
Challenges to Jordanian Muslim men with prostate cancer
Abdulmalik Hasanain - Victoria University of Wellington, Wellington, New Zealand
8 May 2019
5' UTR mutations in prostate cancer
Dr Yiting Lim, Fred Hutchinson Cancer Research Center, Seattle, USA
15 Apr 2019
Evaluation of M7824, a bifunctional fusion protein targeting TGF-β and PD-L1, in...
Dr James Gulley - National Cancer Institute, Bethesda, USA
15 Apr 2019
Risk factors for prostate cancer in men of African descent
Dr Faruk Mohammed - Ahmadu Bello University, Zaria, Nigeria
15 Apr 2019
